MORE►
biotech
Dennis K. Stone [Photo: BioNTX]
Nominate Now: BioNTX Dennis K. Stone Award Recognizes Positive Impact in North Texas Biotech and Life Science Research
by bionorthTX | Sep 14, 2021
Deadline for nominations is Friday, September 17. The 2021 award, sponsored by BioLabs at Pegasus Park, will be presented on September 30 at the iC3 Life Science Summit.
The impact that Dr. Dennis K. Stone left on the DFW biotech industry is, without doubt, immeasurable, says BioNTX. Past recipients of the award that honors his memory are Phil Ralston, Lyda Hill, Darlene Boudreaux, Paul Dorman, and Hubert Zajicek.
by Alex Edwards |
Aug 25, 2021
There, Signature Biologics will manufacture perinatal-derived products that improve the body's natural healing processes in wound, musculoskeletal, and pain management applications.
MORE►
by Alex Edwards |
Aug 10, 2021
A mid-December opening is planned for BioLabs' first central U.S. location in Dallas. Inside the Biotech+ Hub at Pegasus Park, BioLabs will serve as the key operator of the biotech laboratory and 37,000-square-foot flexible life science coworking facility.
MORE►
by David Seeley |
Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
MORE►
[Photo: Jessica Hilton]
How Allied BioScience’s Chief Marketing Officer Blurs a Traditional Work/Life Balance
by Alex Edwards | Mar 8, 2021
As CMO at the Dallas-based biotech, Jessica Hilton is part of a team working to launch the first-ever long-lasting cleaner that can fight COVID-19. It's a job she took during the middle of the global pandemic—and though her home life looks a little different, the mom of three is managing it all through a deep-seeded passion and supportive family.
MORE►
by Quincy Preston |
Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE►
by Alex Edwards |
Feb 16, 2021
Doloromics, a local therapeutics discovery startup that uses technology to find better ways to treat chronic pain, is one of nine companies selected.
MORE►
by Quincy Preston and Sandra Engelland |
Feb 11, 2021
Here are 32 North Texas startups that successfully pulled in capital to back their ventures.
Fitting the digital demands of a global pandemic, it's a tech-heavy group, with liberal doses of biotech and healthcare-related firms.
MORE►
The main building at Pegasus Park.[Image: GFF]
TechFW’s ThinkLab Startup Accelerator Will Expand to Dallas in Partnership with Pegasus Park Next Month
by Lauren Hawkins | Dec 8, 2020
Dallas life science startups are invited to apply to ThinkLab's winter cohort, which will begin in late January 2021.
MORE►
by Alex Edwards |
Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE►
by Sandra Engelland |
Nov 10, 2020
The Eos Bioreactor, which also has been featured in Popular Mechanics, uses algae to "eat" CO2.
MORE►
by Lauren Hawkins |
Oct 27, 2020
The Dallas-based leader will receive the award from BionorthTX for his contributions to the field of life sciences.
MORE►
[Image: Oleksandr Bushko/istockphoto]
UTSW Scientist: ‘We Need More Women Thinking Creatively in the Lab and Pushing Science Forward’
by Quincy Preston | Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
![Illustration of the Orthofix FIREBIRD SI Fusion System with NANOVATE technology [PHOTO: Business Wire]](https://s24806.pcdn.co/wp-content/uploads/2020/10/Orthofix-970-businesswire-360x203.jpg)
by Quincy Preston |
Oct 7, 2020
The Lewisville-based company's new fusion system is designed to compress and stabilize the sacroiliac joint. Its high-tech features make it the first of its kind specifically designed for SI joint solutions.
Other recent news includes a $10 million partnership with a Swiss medtech firm and a new division president.
Other recent news includes a $10 million partnership with a Swiss medtech firm and a new division president.
MORE►
by Gloria Salinas, Managing Director, Economic Development, DRC |
Oct 1, 2020
Dr. Lynda Stuart of the Bill & Melinda Gates Foundation talked with philanthropist and entrepreneur Lyda Hill in a virtual discussion moderated by Nicole Small, CEO of LH Capital/Lyda Hill Philanthropies.
Here's the takeaway.
Here's the takeaway.
MORE►
![At the Fourth Annual iC3 Life Science Summit at UT Arlington on Oct. 10, 2017 recipient Lyda Hill will present the award. To register for the summit, visit www.bionorthtx.org. [Illustration: bestbrk/istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2018/09/Bionorthconcept_970_bestbrk_istockphotovector-molecule-background-genetic-and-chemical-compounds-abstract-vector-id908258902-360x203.jpg)
by Quincy Preston |
Sep 22, 2020
Networking—always a highlight of the biotech event— is still a cornerstone thanks to a new virtual conference platform, its organizers said.
MORE►
